B 
Beijing Chunlizhengda Medical Instruments Co 688236.SS · CNY
Health Care · Shanghai · 🇨🇳 China
13.36
-1.76%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥1.05bn
FY2016FY2025
Net income
CN¥272.5m
FY2016FY2025
Free cash flow
CN¥352.0m
FY2016FY2025
Shareholders' equity
CN¥2.99bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥1.05bn | CN¥690.5m | CN¥1.04bn | CN¥1.03bn | CN¥1.11bn | CN¥937.7m | CN¥855.3m | CN¥497.9m | CN¥300.3m | CN¥207.9m |
| Gross profit | CN¥653.4m | CN¥442.6m | CN¥750.5m | CN¥782.8m | CN¥854.5m | CN¥680.8m | CN¥593.5m | CN¥317.9m | CN¥216.3m | CN¥159.7m |
| Research and development | CN¥118.5m | CN¥114.0m | CN¥134.9m | CN¥139.1m | CN¥104.8m | CN¥72.6m | CN¥57.7m | CN¥35.5m | CN¥21.2m | CN¥14.3m |
| Operating income | CN¥302.2m | CN¥112.0m | CN¥262.2m | CN¥281.8m | CN¥367.6m | CN¥330.1m | CN¥298.6m | CN¥121.2m | CN¥87.2m | CN¥78.1m |
| Net income | CN¥272.5m | CN¥107.1m | CN¥238.1m | CN¥263.7m | CN¥322.4m | CN¥283.4m | CN¥236.8m | CN¥105.6m | CN¥68.3m | CN¥63.4m |
| Diluted earnings per share | 0.71 | 0.29 | 0.61 | 0.67 | 0.93 | 0.82 | 0.68 | 0.31 | 0.20 | 0.19 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥3.66bn | CN¥3.47bn | CN¥3.65bn | CN¥3.41bn | CN¥3.00bn | CN¥1.54bn | CN¥1.21bn | CN¥814.7m | CN¥633.7m | CN¥540.1m |
| Cash and short-term investments | CN¥2.22bn | CN¥1.89bn | CN¥2.10bn | CN¥1.72bn | CN¥1.74bn | CN¥690.1m | CN¥464.2m | CN¥414.9m | CN¥371.6m | CN¥297.3m |
| Total liabilities | CN¥591.9m | CN¥644.4m | CN¥770.3m | CN¥690.1m | CN¥530.6m | CN¥460.4m | CN¥402.7m | CN¥186.6m | CN¥95.2m | CN¥59.2m |
| Debt | CN¥3.8m | CN¥866,436 | CN¥1.8m | CN¥1.3m | CN¥1.2m | CN¥1.9m | CN¥7.2m | CN¥2.0m | — | — |
| Shareholders' equity | CN¥2.99bn | CN¥2.82bn | CN¥2.88bn | CN¥2.72bn | CN¥2.47bn | CN¥1.08bn | CN¥806.6m | CN¥628.1m | CN¥538.5m | CN¥480.9m |
| Shares outstanding | 384m | 368m | 391m | 395m | 348m | 345m | 351m | 345m | 342m | 341m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥409.6m | −CN¥1.6m | CN¥511.7m | CN¥41.0m | CN¥164.8m | CN¥260.7m | CN¥231.5m | CN¥108.5m | CN¥89.8m | CN¥64.9m |
| Capital spending | −CN¥57.6m | −CN¥42.1m | −CN¥33.2m | −CN¥24.9m | −CN¥199.4m | −CN¥24.0m | −CN¥132.4m | −CN¥52.1m | −CN¥9.0m | −CN¥8.4m |
| Free cash flow | CN¥352.0m | −CN¥43.8m | CN¥478.5m | CN¥16.1m | −CN¥34.6m | CN¥236.7m | CN¥99.1m | CN¥56.4m | CN¥80.9m | CN¥56.6m |
| Dividends paid | −CN¥96.4m | −CN¥146.1m | −CN¥120.1m | −CN¥50.0m | — | −CN¥11.9m | −CN¥56.8m | −CN¥16.0m | −CN¥10.7m | −CN¥6.1m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥200.1m | CN¥215.0m | CN¥285.4m | CN¥268.4m | CN¥257.8m | CN¥196.9m | CN¥255.0m | CN¥109.8m |
| Gross profit | CN¥125.5m | CN¥142.5m | CN¥172.8m | CN¥181.5m | CN¥146.9m | CN¥131.3m | CN¥140.7m | CN¥73.3m |
| Operating income | CN¥67.0m | CN¥62.3m | CN¥78.6m | CN¥77.0m | CN¥62.8m | CN¥55.3m | CN¥55.9m | −CN¥14.4m |
| Net income | CN¥58.2m | CN¥61.2m | CN¥79.8m | CN¥77.0m | CN¥56.4m | CN¥49.8m | CN¥54.7m | −CN¥15.3m |
| Diluted earnings per share | 0.15 | 0.16 | 0.21 | 0.20 | 0.15 | 0.13 | 0.15 | -0.04 |
| Cash from operations | CN¥45.0m | −CN¥10.0m | CN¥236.0m | CN¥34.0m | CN¥216.0m | −CN¥64.0m | CN¥13.0m | CN¥44.0m |
| Capital spending | −CN¥7.0m | −CN¥19.0m | −CN¥10.0m | −CN¥18.0m | −CN¥11.0m | −CN¥15.0m | −CN¥14.0m | −CN¥8.0m |
| Free cash flow | CN¥38.0m | −CN¥29.0m | CN¥226.0m | CN¥16.0m | CN¥205.0m | −CN¥79.0m | −CN¥1.0m | CN¥36.0m |
| Total assets | CN¥3.59bn | CN¥3.62bn | CN¥3.66bn | CN¥3.54bn | CN¥3.49bn | CN¥3.47bn | CN¥2.97bn | CN¥2.99bn |
| Cash and short-term investments | CN¥2.13bn | CN¥2.10bn | CN¥2.22bn | CN¥2.00bn | CN¥2.00bn | CN¥1.80bn | CN¥1.62bn | CN¥1.65bn |
| Debt | CN¥2.6m | CN¥2.0m | CN¥6.5m | CN¥218,586 | CN¥403,452 | CN¥838,759 | CN¥742,426 | CN¥793,473 |
| Shareholders' equity | CN¥3.05bn | CN¥3.04bn | CN¥2.99bn | CN¥2.98bn | CN¥2.91bn | CN¥2.88bn | CN¥2.42bn | CN¥2.39bn |
Financial ratios
Data as of 9 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 100.0% | 64.1% | 70.8% | 74.9% | 76.2% | 72.6% | — |
| Operating margin | 28.9% | 16.5% | 25.3% | 28.1% | 33.2% | 35.2% | — |
| Net margin | 26.1% | 15.5% | 23.0% | 25.6% | 29.1% | 30.2% | — |
| Return on equity | 9.1% | 4.4% | 9.7% | 11.3% | 13.1% | 26.2% | — |
| Return on assets | 7.4% | 3.6% | 7.6% | 9.0% | 10.7% | 18.4% | — |
| Free cash flow yield | — | 0.9% | 9.8% | 1.2% | 7.4% | 5.8% | 7.3% |
| Revenue growth | 29.5% | -33.3% | 0.6% | 8.4% | 18.2% | 9.6% | — |
| Earnings growth | 117.7% | -55.0% | -9.7% | -4.5% | 13.8% | 19.7% | — |
| Current ratio | 5.20x | 5.20x | 4.44x | 4.66x | 5.57x | 3.41x | — |
| Debt to equity | — | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | — |
| Equity ratio | 81.6% | 81.4% | 78.8% | 79.8% | 82.3% | 70.1% | — |
| Interest coverage | 7693.96x | 129.24x | 839.42x | 1348.18x | 1433.00x | 2330.44x | — |
| R&D as a share of sales | 11.4% | 16.5% | 13.0% | 13.5% | 9.5% | 7.7% | — |
| Buybacks as a share of market value | -4.2% | 5.7% | 1.1% | -13.3% | -0.9% | 1.5% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 0.5% | 2.2% | 19.4% |
| Operating income | 2.4% | -1.7% | 22.7% |
| Net income | 1.1% | -0.8% | 21.8% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 63.1% | 69.2% | 71.2% | 70.7% |
| Operating margin | 23.9% | 25.2% | 28.3% | 28.9% |
| Net margin | 21.9% | 23.2% | 25.4% | 25.3% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Price to earnings | 32.2 | 44.0 | 43.1 | 35.6 | 29.6 |
| Price to sales | 8.4 | 6.8 | 9.9 | 9.1 | 8.6 |
Dividends and splits
Per share, in the currency the company pays
Paid for 4 years. Last went ex-dividend on 3 Jul 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Paid in the year | 0.15 | 0.259 | 0.445 | 0.313 | 0.13 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.